Literature DB >> 18467498

An improved SUMO fusion protein system for effective production of native proteins.

Chien-Der Lee1, Hui-Chien Sun, Su-Ming Hu, Ching-Feng Chiu, Atthachai Homhuan, Shu-Mei Liang, Chih-Hsiang Leng, Ting-Fang Wang.   

Abstract

Expression of recombinant proteins as fusions with SUMO (small ubiquitin-related modifier) protein has significantly increased the yield of difficult-to-express proteins in Escherichia coli. The benefit of this technique is further enhanced by the availability of naturally occurring SUMO proteases, which remove SUMO from the fusion protein. Here we have improved the exiting SUMO fusion protein approach for effective production of native proteins. First, a sticky-end PCR strategy was applied to design a new SUMO fusion protein vector that allows directional cloning of any target gene using two universal cloning sites (Sfo1 at the 5'-end and XhoI at the 3'-end). No restriction digestion is required for the target gene PCR product, even the insert target gene contains a SfoI or XhoI restriction site. This vector produces a fusion protein (denoted as His(6)-Smt3-X) in which the protein of interest (X) is fused to a hexahistidine (His(6))-tagged Smt3. Smt3 is the yeast SUMO protein. His(6)-Smt3-X was purified by Ni(2+) resin. Removal of His(6)-Smt3 was performed on the Ni(2+) resin by an engineered SUMO protease, His(6)-Ulp1(403-621)-His(6). Because of its dual His(6) tags, His(6)-Ulp1(403-621)-His(6) exhibits a high affinity for Ni(2) resin and associates with Ni(2+) resin after cleavage reaction. One can carry out both fusion protein purification and SUMO protease cleavage using one Ni(2+)-resin column. The eluant contains only the native target protein. Such a one-column protocol is useful in developing a better high-throughput platform. Finally, this new system was shown to be effective for cloning, expression, and rapid purification of several difficult-to-produce authentic proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467498      PMCID: PMC2442006          DOI: 10.1110/ps.035188.108

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  26 in total

1.  Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast.

Authors:  E Mossessova; C D Lima
Journal:  Mol Cell       Date:  2000-05       Impact factor: 17.970

Review 2.  Foot and mouth disease.

Authors:  Gareth Davies
Journal:  Res Vet Sci       Date:  2002-12       Impact factor: 2.534

3.  An efficient system for high-level expression and easy purification of authentic recombinant proteins.

Authors:  Ann-Maree Catanzariti; Tatiana A Soboleva; David A Jans; Philip G Board; Rohan T Baker
Journal:  Protein Sci       Date:  2004-05       Impact factor: 6.725

4.  Enterovirus 71: the virus, its infections and outbreaks.

Authors:  M Ho
Journal:  J Microbiol Immunol Infect       Date:  2000-12       Impact factor: 4.399

5.  Non-covalent interaction between nucleocapsid protein of Tula hantavirus and small ubiquitin-related modifier-1, SUMO-1.

Authors:  Pasi Kaukinen; Antti Vaheri; Alexander Plyusnin
Journal:  Virus Res       Date:  2003-03       Impact factor: 3.303

6.  Self-polymerization of archaeal RadA protein into long and fine helical filaments.

Authors:  Ming-Hui Lee; Chih-Hsiang Leng; Yuan-Chih Chang; Chia-Cheng Chou; Yi-Kai Chen; Fu-Fei Hsu; Chia-Seng Chang; Andrew H-J Wang; Ting-Fang Wang
Journal:  Biochem Biophys Res Commun       Date:  2004-10-22       Impact factor: 3.575

7.  Heterodimeric complexes of Hop2 and Mnd1 function with Dmc1 to promote meiotic homolog juxtaposition and strand assimilation.

Authors:  Yi-Kai Chen; Chih-Hsiang Leng; Heidi Olivares; Ming-Hui Lee; Yuan-Chih Chang; Wen-Mei Kung; Shih-Chieh Ti; Yu-Hui Lo; Andrew H-J Wang; Chia-Seng Chang; Douglas K Bishop; Yi-Ping Hsueh; Ting-Fang Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

8.  SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins.

Authors:  Michael P Malakhov; Michael R Mattern; Oxana A Malakhova; Mark Drinker; Stephen D Weeks; Tauseef R Butt
Journal:  J Struct Funct Genomics       Date:  2004

9.  High-throughput screening of soluble recombinant proteins.

Authors:  Yan-Ping Shih; Wen-Mei Kung; Jui-Chuan Chen; Chia-Hui Yeh; Andrew H-J Wang; Ting-Fang Wang
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

10.  Association of the nucleocapsid protein of the Seoul and Hantaan hantaviruses with small ubiquitin-like modifier-1-related molecules.

Authors:  Byoung-Hee Lee; Kumiko Yoshimatsu; Akihiko Maeda; Kazuhiko Ochiai; Masami Morimatsu; Koichi Araki; Michiko Ogino; Shigeru Morikawa; Jiro Arikawa
Journal:  Virus Res       Date:  2003-12       Impact factor: 3.303

View more
  44 in total

1.  High-level expression and purification of heparin-binding epidermal growth factor (HB-EGF) with SUMO fusion.

Authors:  Wuguang Lu; Peng Cao; Huangzong Lei; Shuangquan Zhang
Journal:  Mol Biotechnol       Date:  2010-03       Impact factor: 2.695

2.  Purification, crystallization and preliminary X-ray crystallographic studies of KstR2 (ketosteroid regulatory protein) from Mycobacterium tuberculosis.

Authors:  Stephanie S Dawes; Sharon L Kendall; Edward N Baker; J Shaun Lott
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-11-14       Impact factor: 1.056

3.  Cross-protective efficacy of recombinant transferrin-binding protein A of Haemophilus parasuis in guinea pigs.

Authors:  Xiaohui Huang; Yu Li; Yuguang Fu; Yanhong Ji; Kaiqi Lian; Haixue Zheng; Jianzhong Wei; Xuepeng Cai; Qiyun Zhu
Journal:  Clin Vaccine Immunol       Date:  2013-04-24

4.  Measuring translational diffusion coefficients of peptides and proteins by PFG-NMR using band-selective RF pulses.

Authors:  Shenggen Yao; Daniel K Weber; Frances Separovic; David W Keizer
Journal:  Eur Biophys J       Date:  2014-05-14       Impact factor: 1.733

5.  Soluble Production of Human Recombinant VEGF-A121 by Using SUMO Fusion Technology in Escherichia coli.

Authors:  Rufus Vinod Munawar Samuel; Syeda Yumna Farrukh; Sadia Rehmat; Muhammad Umair Hanif; Syed Shoaib Ahmed; Syed Ghulam Musharraf; Faiza Gul Durrani; Mahjabeen Saleem; Roquyya Gul
Journal:  Mol Biotechnol       Date:  2018-08       Impact factor: 2.695

6.  Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality.

Authors:  Jo Ishizawa; Sarah F Zarabi; R Eric Davis; Ondrej Halgas; Takenobu Nii; Yulia Jitkova; Ran Zhao; Jonathan St-Germain; Lauren E Heese; Grace Egan; Vivian R Ruvolo; Samir H Barghout; Yuki Nishida; Rose Hurren; Wencai Ma; Marcela Gronda; Todd Link; Keith Wong; Mark Mabanglo; Kensuke Kojima; Gautam Borthakur; Neil MacLean; Man Chun John Ma; Andrew B Leber; Mark D Minden; Walid Houry; Hagop Kantarjian; Martin Stogniew; Brian Raught; Emil F Pai; Aaron D Schimmer; Michael Andreeff
Journal:  Cancer Cell       Date:  2019-05-02       Impact factor: 31.743

7.  Conserved cysteines in Mason-Pfizer monkey virus capsid protein are essential for infectious mature particle formation.

Authors:  Růžena Píchalová; Tibor Füzik; Barbora Vokatá; Michaela Rumlová; Manuel Llano; Alžběta Dostálková; Ivana Křížová; Tomáš Ruml; Pavel Ulbrich
Journal:  Virology       Date:  2018-06-12       Impact factor: 3.616

8.  The N-terminal domain of Escherichia coli RecA have multiple functions in promoting homologous recombination.

Authors:  Chien-Der Lee; Ting-Fang Wang
Journal:  J Biomed Sci       Date:  2009-04-01       Impact factor: 8.410

9.  Production of FMDV virus-like particles by a SUMO fusion protein approach in Escherichia coli.

Authors:  Chien-Der Lee; Yao-Pei Yan; Shu-Mei Liang; Ting-Fang Wang
Journal:  J Biomed Sci       Date:  2009-08-11       Impact factor: 8.410

10.  Ebp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity.

Authors:  S-M Oh; Z Liu; M Okada; S-W Jang; X Liu; C-B Chan; H Luo; K Ye
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.